Century Therapeutics (IPSC) Revenue (2022 - 2025)

Century Therapeutics (IPSC) has 4 years of Revenue data on file, last reported at $109.2 million in Q1 2025.

• Revenue for Q1 2025 came in at $109.2 million, up 12667.72% year-over-year; the trailing twelve-month figure through Dec 2025 was $109.2 million (up 1556.51% YoY), and the FY2025 annual result was $109.2 million, up 1556.76% from the prior year.
• Revenue rose to $109.2 million in Q1 2025 per IPSC's latest filing, from $4.2 million in the prior quarter.
• Over five years, Revenue peaked at $109.2 million in Q1 2025 and troughed at $99000.0 in Q2 2023.
• A 4-year average of $9.5 million and a median of $855000.0 in 2024 frame the typical range for Revenue.
• The sharpest annual moves came in 2023 and 2025: Revenue plunged 93.35% in 2023, then soared 12667.72% in 2025.
• A 4-year view of Revenue shows it stood at $521000.0 in 2022, then tumbled by 48.56% to $268000.0 in 2023, then jumped by 1457.09% to $4.2 million in 2024, then surged by 2515.96% to $109.2 million in 2025.
• Business Quant data shows IPSC's Revenue at $109.2 million in Q1 2025, $4.2 million in Q4 2024, and $791000.0 in Q3 2024.